MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Capital expenditures 2022–2025
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$35,000FY2025 · since FY2022: $16,009 → $35,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $35,000 | -93.3% |
| FY2024 | $520,000 | +83.1% |
| FY2023 | $284,000 | +1674.0% |
| FY2022 | $16,009 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice